AQP4 and neuromyelitis optica: Totally 1,774 subjects were initially enrolled, including 1,082 HCs, 290 AQP4 antibody positive neuromyelitis optica spectrum disorders (AQP4 + NMOSD) and 402 multiple sclerosis (MS) cases.